Novo Nordisk’s Summer Rally Hinges on Buybacks, Data Readouts, and a Cybersecurity Shadow
The Danish drugmaker’s stock has clawed back nearly 40?% from its March trough, touching €42.19 in recent trading…
Novo Nordisk’s Oral Wegovy Gets UK Nod as Cyber Breach Casts a Shadow
It has been a year since Novo Nordisk’s shares touched an all-time high above €70. Now trading at…
Novo Nordisk: A Stock Caught Between Eli Lilly’s Shadow and an AI-Led Renaissance
Novo Nordisk’s shares are nursing a near-47% loss over the past year, and the latest clinical data did…